REG - Frenkel Topping Grp - Trading Update

Frenkel ToppingAnnouncement

29/08/2024 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240829:nRSc0610Ca&default-theme=true

RNS Number : 0610C  Frenkel Topping Group PLC  29 August 2024

The information contained within this announcement was deemed by the Company
to constitute inside information as stipulated under the Market Abuse
Regulations (EU) No. 596/2014 as it forms part of UK domestic law by virtue of
the European Union (Withdrawal) Act 2018 as amended.  With the publication of
this announcement via a Regulatory Information Service, this inside
information is now considered to be in the public domain.

 

Frenkel Topping Group plc

("Frenkel Topping", the "Company" or the "Group")

Trading Update to 30 June 2024

Frenkel Topping (AIM: FEN), a specialist financial and professional services
firm operating within the personal injury (PI) and clinical negligence (CN)
marketplace provides the following trading update for the six-month period
ended 30(th) June 2024 ("HY2024") and an outlook for the remainder of the
financial year ("FY2024").

                    H1 2024*  H1 2023*  % change  FY2023

                    (£m)      (£m)                Full year (£m)
 Revenue            17.9      16.0      12%       32.8
 Recurring revenue  6.5       5.9       10%       12.0
 Gross profit       6.9       6.6       5%        13.9
 Adjusted EBITDA    3.6       3.5       3%        8.0
 FUM                1,455     1,261     15%       1,335
 DFM                935       761       23%       820

*Unaudited - Financial expectations noted above are preliminary and subject to
final review processes.

**EBITDA before share based compensation, acquisition strategy, integration
and reorganisation costs

The first six months saw strategic progress and a solid performance from the
majority of the Group's subsidiaries. One of the Group's subsidiaries
performed less strongly and remedial action has been taken.

A highlight of the performance was the record levels of new Funds Under
Management (FUM) added in the first six months of the year, and that momentum
is expected to continue during the second half.  However, due to continued
market conditions a large proportion of these mandates have been into our
Money Market Solution (MMS) at lower fee rates. MMS was launched in June 2023
and stands at £113.5m at 30(th) June 2024.  We remain poised to redeploy
these mandates into our other investment solutions as market conditions
change.

We were delighted that Ascencia Investment Management's Safety First 2 & 3
portfolios have been Highly Commended in the Defaqto Defensive Comparator
Sector. Based on 5 years discrete risk-adjusted performance measures, the
Defaqto MPS Comparator awards recognises the most consistent MPS solutions
within the Defensive comparator sector.

Additionally, Ascencia has been awarded with the ARC 3D Research Award this
year. This annual award has 3 founding principles: Data, Due Diligence and
Demonstration.

Ascencia has continued to outperform benchmarks, with our Income and Growth 4
fund achieving returns of 4.92% on the three years to 30(th) June 2024
compared to ARC Sterling Balanced Asset's return of 3.29%.

Fair value assessment and associated amendments to charging structures in
light of the regulatory changes around Consumer Duty have been largely
completed and the Board is confident that there are no material regulatory
implications that have not been sufficiently addressed.

The amended charging structures will have a modest impact on revenues, with
limited impact this financial year.

Partners in Costs Limited ("PIC"), one of the UK's leading costs law
specialists, has had a particularly challenging period primarily in
recruitment and technology implementation impacting their ability to handle
increased workloads. The Board has taken swift action and have changed a
number of key processes as a result. It is making a number of new hires and is
continuing to invest in technology which is expected to improve medium-term
performance. The Board is confident that the medium-term prospects for PIC
remain positive and that this is a short-term issue, but the underperformance
will have an impact on the outturn and management's expectations for the year
of the Group.

Somek & Associates has continued to increase the number of expert
witnesses, increasing our ability to handle higher number of instructions.
During FY2023 we grew this number by 19% and have already achieved a further
17% growth during H1 2024. This remains a key objective for the second half of
the year and beyond.

May saw Cardinal increase its presence in NHS Major Trauma Centres (MTC)
through the addition of Sheffield Children's Hospital to its portfolio.  We
continue to work with the NHS to demonstrate the benefits of these services to
them and remain committed to increasing our presence within further MTC in
order to better support the interests of claimants and the work of their
professional representatives.

Bidwell Henderson continue to expand the Graduate training programme and have
taken on two intakes to date in H1 with the next due to start in the Autumn.
We continue to develop this programme and are looking at ways we can expand
its reach within our wider Costs businesses in order to produce a pipeline of
future Costs experts.

Within Care and Case Management we are continuing to increase our geographical
reach, with key hires being made in Doncaster and Birmingham with a view to
offering our services nationwide.

Following the acquisition of North West Law Services (NWL) in April, key
relationships have been retained and NWL is trading in line with our
expectations.

Outlook

The business takes confidence from FUM growth and performance across many of
the business units but the impact of the underperformance of PIC and the
amendments to  charging structures due to Consumer Duty means that the
Company is currently trading in line with revenue expectations but slightly
behind management's expectations of EBITDA by c.8 per cent. It does however
take encouragement from having taken immediate action to address matters at
PIC and overall the opportunity remains to consolidate its position as the
leader in financial and professional services in the PI and CN space and that
the vast majority of businesses acquired have integrated well and are
performing to management's expectations.

Notice of Results

Final, unaudited results for the six months ended 30 June 2024 are expected to
be announced on 30th September 2024 at which point management will provide a
further and more comprehensive update on progress and strategy.

 

For further information:

 Frenkel Topping Group plc                                      www.frenkeltoppinggroup.co.uk (http://www.frenkeltoppinggroup.co.uk/)
 Richard Fraser, Chief Executive Officer                        Tel: 0161 886 8000

 Cavendish Capital Markets Ltd (NOMAD & Broker)                 Tel: 020 7220 0500
 Carl Holmes/Abigail Kelly/Fergus Sullivan (Corporate Finance)

 Tim Redfern (ECM)

 

About Frenkel Topping Group

The Frenkel Topping Group of companies specialises in providing financial
advice and asset protection services to clients at times of financial
vulnerability, with particular expertise in the field of personal injury (PI)
and clinical negligence (CN).

For more than 30 years the Group has worked with legal professionals and
injured clients themselves to provide pre-settlement, at-settlement and
post-settlement services to help achieve the best long-term outcomes for
clients after injury. It boasts a client retention rate of 99%.

Frenkel Topping Group is focused on consolidating the fragmented PI and CN
space in order to provide the most comprehensive suite of services to clients
and deliver a best-in-class service offering from immediately after injury or
illness and for the rest of their lives.

The Group's services include the Major Trauma Signposting Partnership service
inside NHS Major Trauma Centres, expert witness, costs, tax and forensic
accountancy, independent financial advice, investment management, and care and
case management.

The Group's discretionary fund manager, Ascencia, manages financial portfolios
for clients in unique circumstances, often who have received a financial
settlement after litigation. In recent years Ascencia has diversified its
portfolios to include a Sharia-law-compliant portfolio and a number of ESG
portfolios in response to increased interest in socially responsible investing
(SRI).

Frenkel Topping has earned a reputation for commercial astuteness underpinned
by a strong moral obligation to its clients, employees and wider society, with
a continued focus on its Environmental, Social and Governance (ESG) impact.

 

For more information visit:      www.frenkeltoppinggroup.co.uk
(http://www.frenkeltoppinggroup.co.uk)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  TSTSEMFWAELSESA